HRS2398 / Jiangsu Hengrui Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HRS2398 / Jiangsu Hengrui Pharma
NCT06439589: Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Not yet recruiting
1/2
88
RoW
HRS2398, Adebrelimab
Shanghai Hengrui Pharmaceutical Co., Ltd.
Advanced Solid Tumors
12/25
12/25

Download Options